Augmented renal clearance, often abbreviated ARC, describes a condition in which the kidneys filter blood at a rate well above what would be expected for a given patient. It has been recognized for more than a decade in critically ill trauma and sepsis patients, where it is usually treated as a pharmacokinetic problem: drugs that are cleared by the kidneys, particularly antibiotics, are eliminated so quickly that standard doses may fail to reach therapeutic levels in the blood. The Montreal team, led by neurosurgeon Kazunori Oda, set out to ask a different question. Rather than viewing the hyperfiltering kidney purely as a dosing challenge, they hypothesized that it might serve as a window into a broader hyperdynamic state, one that also drives the catabolic firestorm that follows severe brain injury.

The study examined intensive care unit admissions of adults with severe traumatic brain injury at a tertiary academic level I trauma center between 2015 and 2024. Because directly measured urinary creatinine clearance was not systematically available in this retrospective setting, the researchers relied on serum-creatinine-estimated creatinine clearance, calculated from routine blood work. They defined estimated augmented renal clearance, or eARC, as an estimated creatinine clearance of at least 130 milliliters per minute per 1.73 square meters of body surface area at one or more time points during the first 28 days after injury. This threshold is consistent with definitions used widely in the critical care literature, where values above 130 are generally considered supranormal.

Of the 342 admissions included in the analysis, eARC occurred in 197 patients, or 57.6 percent. That figure is striking: it means that in this population, a hyperfiltering kidney was the rule rather than the exception. The patients who developed eARC were younger, more often male, and had lower admission Glasgow Coma Scale scores, suggesting more severe impairment of consciousness at presentation. These demographic and clinical associations echo earlier work showing that young trauma patients with robust physiological reserve are the ones most likely to mount an exaggerated renal response, even as their brains bear the brunt of the injury.

The central finding of the study concerns body weight. Patients with eARC experienced a median day-28 body weight loss of 12.7 percent, compared with essentially no change, 0.0 percent, in patients without eARC, a difference that was highly statistically significant. Severe weight loss was also markedly more frequent in the eARC group. To put the magnitude in perspective, a double-digit percentage loss of body mass within a month is far beyond what would be expected from simple fluid shifts or reduced appetite; it points to substantial depletion of lean tissue and fat stores, the kind of catabolic erosion that has been associated with worse outcomes in critically ill and neurotrauma populations.

To make sure the association was not an artifact of confounding, the investigators took a rigorous approach to variable selection, guided by a directed acyclic graph, a formal framework that maps out plausible causal relationships and identifies which covariates must be adjusted for. In exploratory multivariable analysis adjusting for age and admission Glasgow Coma Scale score, eARC remained independently associated with severe day-28 weight loss. The team also ran a battery of sensitivity analyses designed to rule out alternative explanations. They incorporated calories derived from propofol, the sedative commonly infused in brain-injured patients, which is delivered in a lipid emulsion and can contribute substantial energy intake that is often overlooked in nutrition calculations.

Those sensitivity analyses proved revealing in their own right. Once propofol-derived calories were counted, total energy delivery turned out to be similar between the eARC and non-eARC groups, which weakens the argument that the weight loss simply reflected underfeeding. Likewise, serum sodium concentrations, total fluid input, urine output, and the input-minus-urine fluid balance estimate did not show clear group-level differences that could account for the observed weight-loss gap. In other words, the excess weight loss in eARC patients could not be readily explained by either a caloric deficit or by large-scale fluid and electrolyte shifts, leaving a primary metabolic or catabolic mechanism as the leading candidate.

The biological plausibility of such a mechanism is supported by a growing body of literature. Severe traumatic brain injury is known to trigger one of the most intense hypermetabolic states in medicine, with resting energy expenditure and nitrogen excretion rising sharply in the first weeks after injury. Previous observational work has linked augmented renal clearance to increased muscle catabolism and urinary nitrogen loss in trauma patients, and studies of atrial natriuretic peptide and cardiac output in brain-injured patients have suggested that the hyperdynamic circulation driving renal hyperfiltration may be part of a systemic stress response. Creatinine itself is generated from muscle, so a rapidly falling serum creatinine in a catabolic patient can inflate clearance estimates while simultaneously signaling loss of muscle mass, a coupling that the authors acknowledge as a limitation of relying on estimated rather than measured clearance.

The clinical implications, if confirmed, could be substantial. If eARC identifies a metabolically vulnerable subgroup of brain-injured patients, then a routine serum creatinine, a test drawn almost daily in every intensive care unit, could become an early warning flag prompting intensified nutritional surveillance, earlier dietitian involvement, closer monitoring of protein delivery, and perhaps pharmacokinetic dose adjustments for renally cleared drugs. The authors are careful to frame their findings as hypothesis generating. Because the study was retrospective and relied on estimated rather than measured creatinine clearance, and because body weight alone cannot distinguish fluid changes from true tissue loss, they call for prospective studies using directly measured creatinine clearance, detailed sodium and water balance assessment, and direct body composition measures such as bioelectrical impedance or imaging-based muscle quantification.

For now, the study adds an intriguing piece to the puzzle of why some brain injury patients waste away despite modern critical care. It suggests that the kidney, an organ rarely at the center of neurotrauma discussions, may be broadcasting a signal about systemic metabolic state that clinicians have been reading only through a pharmacokinetic lens. With more than half of severe traumatic brain injury patients in the cohort showing supranormal renal filtration, and with that subgroup losing on average nearly 13 percent of their body weight in a month, the case for watching the kidneys as metabolic sentinels has become considerably stronger. Whether aggressive, eARC-guided nutritional intervention can change the trajectory for these patients is the question that prospective research must now answer.

Subject of Research: Augmented renal clearance and metabolic weight loss after severe traumatic brain injury

Article Title: Serum-Creatinine-Estimated Augmented Renal Clearance is Associated with Marked Weight Loss after Severe Traumatic Brain Injury

Article References: Oda, K., Nedelcu, R., Abouassaly, M., Mourad, A. A., Grubb, K., Saluja, R. S., & Marcoux, J. (2026). Serum-Creatinine-Estimated Augmented Renal Clearance is Associated with Marked Weight Loss after Severe Traumatic Brain Injury. Neurocritical Care. https://doi.org/10.1007/s12028-026-02666-1

Image Credits: AI Generated

DOI: 10.1007/s12028-026-02666-1

Keywords: augmented renal clearance, traumatic brain injury, neurocritical care, creatinine clearance, weight loss, nutrition, catabolism, fluid balance, intensive care, hypermetabolism, neurotrauma, propofol